ARTICLE IN ACADEMIC JOURNALS
NO | DETAILS OF ARTICLE IN ACADEMIC JOURNALS |
---|---|
1. |
Does dose reduction of afatinib affect treatment outcomes of patients with <i>EGFR</i>-mutant metastatic non-small cell lung cancer in real-world clinical practice?
2024
Author(s) : Poh Mau Ern Source :
TRANSLATIONAL LUNG CANCER RESEARCH
DOI :
10.21037/tlcr-23-691
|
2. |
Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer
2024
Author(s) : Poh Mau Ern Source :
TRANSLATIONAL LUNG CANCER RESEARCH
DOI :
10.21037/tlcr-24-243
|
3. |
Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis
2024
Author(s) : Poh Mau Ern Source :
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
DOI :
10.1164/rccm.202306-1059OC
|
4. |
Identifying the prevalence of severe asthma in a Malaysian tertiary hospital
2023
Source :
RESPIROLOGY
|
5. |
Tissue coagulum clot cellblock from EBUS-TBNA for the diagnosis of necrotic mediastinal lesions
2023
Source :
RESPIROLOGY
|
6. |
The plasmidome in bronchiectasis
2023
Author(s) : Poh Mau Ern Source :
EUROPEAN RESPIRATORY JOURNAL
DOI :
10.1183/13993003.congress-2023.PA1106
|
7. |
Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers
2023
Author(s) : Liam Chong Kin, Pang Yong Kek, Poh Mau Ern, Wong Chee Kuan, Loh Thian Chee, Soo Chun Ian Source :
BMC CANCER
DOI :
10.1186/s12885-023-11156-y
|
8. |
Symptomatic prolonged viral shedding in long COVID - Our experience with remdesivir
2023
Source :
EUROPEAN RESPIRATORY JOURNAL
DOI :
10.1183/13993003.congress-2023.PA3415
|
9. |
Methyprednisolone versus dexamethasone for severe COVID-19 infection: A retrospective comparative analysis of our early experience
2023
Author(s) : Liam Chong Kin, Pang Yong Kek, Poh Mau Ern, Wong Chee Kuan, Loh Thian Chee, Soo Chun Ian Source :
RESPIROLOGY
|
10. |
Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country
2023
Source :
CANCER MANAGEMENT AND RESEARCH
DOI :
10.2147/CMAR.S393729
|
11. |
Sensitisation to recombinant <i>Aspergillus fumigatus</i> allergens and clinical outcomes in COPD
2023
Author(s) : Poh Mau Ern Source :
EUROPEAN RESPIRATORY JOURNAL
DOI :
10.1183/13993003.00507-2022
|
12. |
Tissue coagulum clot cellblock from EBUS-TBNA for the diagnosis of necrotic lung and mediastinal lesions.
2023
Source :
EUROPEAN RESPIRATORY JOURNAL
DOI :
10.1183/13993003.congress-2023.PA477
|
13. |
Diagnostic yield and utility of endobronchial ultrasound-guided transmediastinal cryobiopsy in pulmonary disease: Novel insights from an early retrospective single-center experience in Malaysia
2023
Source :
RESPIROLOGY
|
14. |
Topological Data Analysis (TDA) of Allergic Sensitization in Bronchiectasis and COPD
2022
Author(s) : Poh Mau Ern Source :
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
|
15. |
Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia
2022
Source :
CANCER MANAGEMENT AND RESEARCH
DOI :
10.2147/CMAR.S364713
|
16. |
High Frequency of Allergic Bronchopulmonary Aspergillosis in Bronchiectasis-COPD Overlap
2022
Author(s) : Poh Mau Ern Source :
CHEST
DOI :
10.1016/j.chest.2021.07.2165
|
17. |
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
2022
Author(s) : Poh Mau Ern Source :
TRANSLATIONAL LUNG CANCER RESEARCH
DOI :
10.21037/tlcr-22-318
|
18. |
The antimicrobial resistome in bronchiectasis: an international multicentre study
2022
Author(s) : Poh Mau Ern Source :
EUROPEAN RESPIRATORY JOURNAL
DOI :
10.1183/13993003.congress-2022.1559
|
19. |
Aspergillus sensitization as a treatable trait in COPD
2022
Author(s) : Poh Mau Ern Source :
EUROPEAN RESPIRATORY JOURNAL
DOI :
10.1183/13993003.congress-2022.69
|
20. |
Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country
2022
Source :
THORACIC CANCER
DOI :
10.1111/1759-7714.14442
|
21. |
Persistent respiratory failure in severe COVID-19 patients - A tertiary centre experience in Kuala Lumpur, Malaysia.
2022
Source :
EUROPEAN RESPIRATORY JOURNAL
DOI :
10.1183/13993003.congress-2022.2671
|
22. |
Influenza in Malaysian adult patients hospitalized with community-acquired pneumonia, acute exacerbation of chronic obstructive pulmonary disease or asthma: a multicenter, active surveillance study
2021
Source :
BMC INFECTIOUS DISEASES
DOI :
10.1186/s12879-021-06360-9
|
23. |
Management of Asthma Exacerbations in Southeast Asian Tertiary Care
2021
Author(s) : Liam Chong Kin, Poh Mau Ern Source :
JOURNAL OF ASTHMA AND ALLERGY
DOI :
10.2147/JAA.S309143
|
24. |
Integrative microbiomics in bronchiectasis exacerbations
2021
Author(s) : Poh Mau Ern Source :
NATURE MEDICINE
DOI :
10.1038/s41591-021-01289-7
|
25. |
Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/ beta-catenin signaling pathway in taxol-resistant human lung adenocarcinoma
2021
Author(s) : Poh Mau Ern Source :
TRANSLATIONAL LUNG CANCER RESEARCH
DOI :
10.21037/tlcr-21-145
|
26. |
The bronchiectasis 'bacteriophagome'
2021
Author(s) : Poh Mau Ern Source :
EUROPEAN RESPIRATORY JOURNAL
DOI :
10.1183/13993003.congress-2021.OA1306
|
27. |
Accuracy of lung cancer staging in the multidisciplinary team setting
2020
Author(s) : Poh Mau Ern Source :
TRANSLATIONAL LUNG CANCER RESEARCH
|
28. |
Accuracy of lung cancer staging in the multidisciplinary team setting
2020
Source :
TRANSLATIONAL LUNG CANCER RESEARCH
DOI :
10.21037/tlcr.2019.11.28
|
29. |
Environmental fungal sensitisation associates with poorer clinical outcomes in COPD
2020
Author(s) : Poh Mau Ern Source :
EUROPEAN RESPIRATORY JOURNAL
|
30. |
High-Risk Clinical and Inflammatory Clusters in COPD of Chinese Descent
2020
Author(s) : Poh Mau Ern Source :
CHEST
|
31. |
High-Risk Clinical and Inflammatory Clusters in COPD of Chinese Descent
2020
Author(s) : Poh Mau Ern Source :
CHEST
DOI :
10.1016/j.chest.2020.01.043
|
32. |
Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
2020
Author(s) : Liam Chong Kin, Cheah Phaik Leng, Pang Yong Kek, Ho Gwo Fuang, Adlinda Binti Alip, Poh Mau Ern, Diana Ong Bee Lan Source :
CANCER MANAGEMENT AND RESEARCH
DOI :
10.2147/CMAR.S253760
|
33. |
Environmental fungal sensitisation associates with poorer clinical outcomes in COPD
2020
Author(s) : Poh Mau Ern Source :
EUROPEAN RESPIRATORY JOURNAL
DOI :
10.1183/13993003.00418-2020
|
34. |
Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
2020
Source :
CANCER MANAGEMENT AND RESEARCH
|
35. |
Impact of clinical features on the efficacy of osimertinib treatment in epidermal growth factor receptor mutant non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors due to T790M mutation
2019
Source :
JOURNAL OF THORACIC DISEASE
DOI :
10.21037/jtd.2019.08.117
|
36. |
Epithelial-to-mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy
2019
Author(s) : Poh Mau Ern Source :
THORACIC CANCER
|
37. |
Epithelial-to-mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy
2019
Author(s) : Liam Chong Kin, Man Kein Seong @ Mun Kein Seong, Poh Mau Ern, Wong Chee Kuan, Loh Thian Chee Source :
THORACIC CANCER
|
38. |
Epithelial-to-mesenchymal transition (EMT) causing acquired resistance to afatinib in a patient with epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma
2018
Author(s) : Poh Mau Ern Source :
JOURNAL OF THORACIC DISEASE
|
39. |
Bilateral pulmonary sequestrations mimicking advanced lung malignancy
2018
Author(s) : Poh Mau Ern Source :
JOURNAL OF THORACIC DISEASE
|
40. |
Bilateral pulmonary sequestrations mimicking advanced lung malignancy
2018
Author(s) : Ng Wei Lin, Poh Mau Ern Source :
JOURNAL OF THORACIC DISEASE
|
41. |
Epithelial-to-mesenchymal transition (EMT) causing acquired resistance to afatinib in a patient with epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma
2018
Author(s) : Poh Mau Ern Source :
JOURNAL OF THORACIC DISEASE
|
42. |
Epidermal growth factor receptor mutation in newly diagnosed lung adenocarcinoma
2017
Author(s) : Rafiza Binti Abdul Razak, Shahazwan Bin Mat Yusoff Source :
Journal of Respiratory Medicine and Lung Diseases
|
43. |
EGFR Mutations in Asian Patients with Advanced Lung Adenocarcinoma
2014
Author(s) : Poh Mau Ern Source :
Journal of Thoracic Oncology
|
44. |
Mycobacterium Brisbanense Species Nova Isolated From a Patient With Chronic Cavitary Lung Infection
2014
Author(s) : Poh Mau Ern Source :
Chest
|
45. |
Mycobacterium Brisbanense Species Nova Isolated From a Patient With Chronic Cavitary Lung Infection
2014
Source :
Chest
|
46. |
Acrometastasis from an epidermal-growth-factor-receptor (EGFR) mutation- positive lung adenocarcinoma.
2014
Author(s) : Poh Mau Ern Source :
Cancer Treatment Communications
|
47. |
Endobronchial metastases from resected renal cell carcinoma causing total lung collapse
2013
Author(s) : Poh Mau Ern Source :
Respirology Case Report
|
48. |
Advanced right lung adenocarcinoma with ipsilateral breast metastasis.
2013
Author(s) : Poh Mau Ern Source :
Respirology Case Report
|
49. |
Toxoplasmosis: a silent opportunistic diseases in HIV/AIDS patients.
2007
Author(s) : Poh Mau Ern Source :
Research Journal of Parasitology
|
RESEARCH PROJECT
GRANT | PROGRESS | STATUS |
---|---|---|
Lignosus Rhinocerus Tm02? As An Immunomodulatory Agent For The Treatment Of Uncontrolled Asthma And Allergic Rhinitis: A Randomised, Double Blind, Placebo-control Study
Researcher(s) : Prof. Dr. Fung Shin Yee |
|
end |
RESEARCH COLLABORATOR
GRANT | PROGRESS | STATUS |
---|